TY - JOUR
T1 - Aortic vascular graft infection caused by Cardiobacterium valvarum
T2 - A case report
AU - Hagiya, Hideharu
AU - Kokeguchi, Susumu
AU - Ogawa, Hiroko
AU - Terasaka, Tomohiro
AU - Kimura, Kosuke
AU - Waseda, Koichi
AU - Hanayama, Yoshihisa
AU - Oda, Kaori
AU - Mori, Hisatoshi
AU - Miyoshi, Toru
AU - Otsuka, Fumio
N1 - Publisher Copyright:
© 2014 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
PY - 2014
Y1 - 2014
N2 - A 53-year-old man with a past medical history of total arch replacement surgery and severe aortic regurgitation presented with a 1-month history of persistent general malaise, anorexia, body weight loss and night sweats. His recent history included gingival hyperplasia for 6 years, gingivitis after tooth extraction 3 years before, prolonged inflammatory status for 4 months, fundal hemorrhage and leg tenderness for 2 months. A pathogen was detected from blood culture, but conventional microbiological examination failed to identify the pathogen. The organism was eventually identified as Cardiobacterium valvarum by 16S rRNA analysis, and the patient was diagnosed with infective endocarditis and prosthetic vascular graft infection. The patient received intravenous antibiotic therapy using a combination of ceftriaxone and levofloxacin for 5 weeks and was discharged with a good clinical course. C. valvarum is a rare human pathogen in clinical settings. Only 10 cases have been reported to date worldwide, and therefore, the clinical characteristics of C. valvarum infection are not fully known. This is a first well-described case of C. valvarum infection in Japan, and further, a first report of aortic prosthetic vascular graft infection worldwide. Identification of C. valvarum is usually difficult due to its phenotypic characteristics, and molecular approaches would be required for both clinicians and microbiologists to facilitate more reliable diagnosis and uncover its clinical picture more clearly.
AB - A 53-year-old man with a past medical history of total arch replacement surgery and severe aortic regurgitation presented with a 1-month history of persistent general malaise, anorexia, body weight loss and night sweats. His recent history included gingival hyperplasia for 6 years, gingivitis after tooth extraction 3 years before, prolonged inflammatory status for 4 months, fundal hemorrhage and leg tenderness for 2 months. A pathogen was detected from blood culture, but conventional microbiological examination failed to identify the pathogen. The organism was eventually identified as Cardiobacterium valvarum by 16S rRNA analysis, and the patient was diagnosed with infective endocarditis and prosthetic vascular graft infection. The patient received intravenous antibiotic therapy using a combination of ceftriaxone and levofloxacin for 5 weeks and was discharged with a good clinical course. C. valvarum is a rare human pathogen in clinical settings. Only 10 cases have been reported to date worldwide, and therefore, the clinical characteristics of C. valvarum infection are not fully known. This is a first well-described case of C. valvarum infection in Japan, and further, a first report of aortic prosthetic vascular graft infection worldwide. Identification of C. valvarum is usually difficult due to its phenotypic characteristics, and molecular approaches would be required for both clinicians and microbiologists to facilitate more reliable diagnosis and uncover its clinical picture more clearly.
KW - Aortic vascular graft
KW - Cardiobacterium
KW - Hyperglobulinemia
KW - Infective aneurysm
KW - Infective endocarditis
KW - Septic embolism
UR - http://www.scopus.com/inward/record.url?scp=84939218380&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84939218380&partnerID=8YFLogxK
U2 - 10.1016/j.jiac.2014.07.008
DO - 10.1016/j.jiac.2014.07.008
M3 - Article
C2 - 25242585
AN - SCOPUS:84939218380
SN - 1341-321X
VL - 20
SP - 804
EP - 809
JO - Journal of Infection and Chemotherapy
JF - Journal of Infection and Chemotherapy
IS - 12
ER -